Leading International Peer-reviewed Journals On Pediatric Oncology
Pediatric oncology has experienced great successes within the last 40 years, but daunting challenges must be overcome if these successes are to continue. Only a few therapies wont to treat childhood
cancer today are targeted in nature and as a result, treatment is usually amid significant acute and long-term toxicities. Continued improvement in outcomes requires the event of targeted therapies that are simpler and fewer toxic. We must find out how to effectively and safely integrate targeted therapies like small
molecules and immunotherapy into cytotoxic regimens to enhance outcomes and/or develop these as stand-alone therapies for diseases and subgroups that haven't benefited from dose intensive approaches. Effective therapies must even be made available to patients within the developing world, as regimens that are tolerable and effective in these settings. Our ultimate goal is to supply fair and rapid referee so as to publish scientific advances for the advantage of all members of the pediatric
oncology community, from basic scientists, to clinical researchers, to caregivers. The aim of this section is to assist address these challenges by publishing quality basic science, translational studies and clinical trials within the field of pediatric oncology. Additionally to primary research papers, we welcome focused reviews on recent advances and commentaries on controversial or emerging concepts.
.
High Impact List of Articles
Relevant Topics in